Its particularly effective in: Piglets (white scours, weakness) Calves, kids, and lambs born in parasite-prone areas Animals recovering from blood loss or infections 2
These properties make BPC 157 popular in sports medicine and rehabilitation for supporting recovery from injuries or surgery
Such engagement hinders this vital cellular defense mechanism allowing enhanced pathogenesis while blocking class II antigen presentation, further augmenting HSV virulence (36, 37)
These findings are from clinical trials with pharmaceutical-grade semaglutide under medical supervision
Over 50 years of research sit behind it
Building on the Phase 2 results, the REGENCY trial, a Phase III study, announced in September 2024 that it met its primary endpoint